Sign in

CIK 0001806310

  • Non-accelerated filer
  • Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843199512
Phone
+1 214-612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-23 Nolan Sean P. Director Grant or award · Stock Option (right to buy) +31,000 31,000
2020-09-23 Nagendran Sukumar Director Grant or award · Stock Option (right to buy) +31,000 31,000
2020-09-23 Manning Paul B Director Grant or award · Stock Option (right to buy) +31,000 31,000
2020-09-23 Donenberg Phillip B. Director Grant or award · Stock Option (right to buy) +31,000 31,000
2020-09-23 Alam Kamran Chief Financial Officer Grant or award +331,121 331,121

Page 10 of 10 · 185 trades